Saulo Cabral Bourguignon

Trypanocidal agents with low cytotoxicity to mammalian cell line: A comparison of the theoretical and biological features of lapachone derivatives

Vı́tor F. Ferreira, Alessandra Jorqueira, Alessandra Mendonça Teles de Souza et al. · Bioorganic & Medicinal Chemistry · 2006 · 83 citations

Mammalian Cell Line, Biochemistry, Antiparasitic Agent +8

Leishmania amazonensis: early proteinase activities during promastigote–amastigote differentiation in vitro

Carlos Roberto Alves, Suzana Côrte‐Real, Saulo Cabral Bourguignon et al. · Experimental Parasitology · 2004 · 70 citations

Biochemistry, Parasitic Protozoa, Natural Sciences +5

Potency evaluation of antivenoms in Brazil: The national control laboratory experience between 2000 and 2006

Humberto Pinheiro de Araújo, Saulo Cabral Bourguignon, Maria Aparecida Affonso Boller et al. · Toxicon · 2007 · 69 citations

Drug Safety, Potency Evaluation, Medicine +12

BJ-48, a novel thrombin-like enzyme from the Bothrops jararacussu venom with high selectivity for Arg over Lys in P1: Role of N-glycosylation in thermostability and active site accessibility

Floriano Paes Silva, Herbert Leonel de Matos Guedes, Laura C. Garvey et al. · Toxicon · 2007 · 49 citations

Protein Chemistry, Novel Thrombin-like Enzyme, Protein Function +7

Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound

Leonardo da Silva Lara, Caroline dos Santos Moreira, Cláudia M. Calvet et al. · European Journal of Medicinal Chemistry · 2017 · 48 citations

Promising Hit Compound, Antiparasitic Agent, Medicine +6